Increase in Prevalence of Cachexia
Cachexia is a multifunctional disease that causes extreme weight loss, skeletal muscle and adipose tissue loss, metabolic regulation imbalance, and food intake reduction. It is a serious clinical consequence of almost all chronic diseases when reaching advanced stages. In 2016, cachexia prevalence ranged from 5 to 15% in end-stage chronic heart failure. It is frequently occurring in patients suffering from chronic kidney disease, chronic obstructive pulmonary disease (COPD), neurological disease, and rheumatoid arthritis. Mortality rates of cachexia patients range from 15 to 25% per year in patients with severe COPD and from 20 to 40% per year in patients with chronic heart failure or chronic kidney disease.
Cancer cachexia negatively affects the quality of life of cancer patients and reduces the effectiveness of anticancer chemotherapy and increases its toxicity, leading to growth in cancer-related mortality and medical resources expenditure. In cachexia the nutrient in the body decreases therefore it is necessary to provide external nutrients to continue the treatment for cancer and COPD. Doctors prefer enteral route to provide these required nutrients to the patient. Therefore, growing prevalence of cachexia due to the rising incidence of various chronic diseases fuels the growth of the enteral medical nutrition market.
Market Overview
The North America enteral medical nutrition market has been segmented into the US, Canada, and Mexico. The US held the largest share of the North America enteral medical nutrition market in 2021. The increasing prevalence of chronic diseases followed by rising research and development activities by various major firms, increasing expenditure on patient care, and increasing preference for enteral nutrition ultimately drive the overall enteral medical nutrition market during the forecast period. Further, The US enteral medical nutrition market holds the largest share in the North America region. The rising prevalence of chronic diseases is likely to favor market growth. Chronic diseases such as cancer, heart disease, and diabetes are the leading causes of disability and death in the US. As per the National Center for Chronic Disease Prevention and Health Promotion, six in ten Americans have at least one chronic disease, such as heart disease, stroke, cancer, diabetes, and others.
Increasing expenditure on chronic health conditions is likely to favor market growth. In 2016, the total costs in the US. for direct treatment for chronic diseases was US$1.1 trillion, equivalent to around 6% of the nation’s GDP. Further, in 2020, the total expenditure of chronic diseases in the US reached US$3.7 trillion, which is around 19.6% of the country’s GDP.
The US government is taking many initiatives to boost the enteral nutrition market. For instance, the Feeding Tube Awareness Foundation is creating awareness about feeding tube adoption. The foundation has celebrated the annual Feeding Tube Awareness Week from February 4 to February 8, 2019. More than 500,000 children and adults in the US depend on enteral feeding for nutrition, and the number is expected to increase in the forecast period.
Strategic insights for the North America Enteral Medical Nutrition provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the North America Enteral Medical Nutrition refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.North America Enteral Medical Nutrition Strategic Insights
North America Enteral Medical Nutrition Report Scope
Report Attribute
Details
Market size in 2022
US$ 3,602.61 Million
Market Size by 2028
US$ 5,043.51 Million
Global CAGR (2022 - 2028)
5.8%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Indication
By Nutrition Type
By Form
By Product
By Distribution Channel
Regions and Countries Covered
North America
Market leaders and key company profiles
North America Enteral Medical Nutrition Regional Insights
North America Enteral Medical Nutrition Market Segmentation
The North America enteral medical nutrition market is segmented into indication, nutrition type, form, product, distribution channel, age group and country.
Based on indication, the North America enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. The respiratory disorders segment held the largest share in 2022. Based on nutrition type, the North America enteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held the largest share of the market in 2022. Based on form, the North America enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment held the largest share of the market in 2022. Based on product, the North America enteral medical nutrition market is segmented into standard protein diet, high protein diet, fruit juice based oral nutrition, and others. The standard protein diet segment held the largest share of the market in 2022. Based on distribution channel, the North America Enteral Medical Nutrition market is segmented into Hospital Pharmacies, Retail Stores and Other Pharmacies. The Hospital pharmacies segment held the largest share of the market in 2022. Based on Age Group, the North America enteral medical nutrition market is segmented into child (till 18 years) and adults (above 18 years). The adult segment held the largest share of the market in 2022. Based on country, the market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022. Abbott Laboratories; B. Braun Melsungen AG; DSM Nutritional Products AG; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Meiji Holdings Co., Ltd.; Nestlé S.A.; Nutricia; and Smartfish AS are the leading companies operating in the enteral medical nutrition market in the region.
The North America Enteral Medical Nutrition Market is valued at US$ 3,602.61 Million in 2022, it is projected to reach US$ 5,043.51 Million by 2028.
As per our report North America Enteral Medical Nutrition Market, the market size is valued at US$ 3,602.61 Million in 2022, projecting it to reach US$ 5,043.51 Million by 2028. This translates to a CAGR of approximately 5.8% during the forecast period.
The North America Enteral Medical Nutrition Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Enteral Medical Nutrition Market report:
The North America Enteral Medical Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Enteral Medical Nutrition Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Enteral Medical Nutrition Market value chain can benefit from the information contained in a comprehensive market report.